0001209191-16-151019.txt : 20161117
0001209191-16-151019.hdr.sgml : 20161117
20161117193255
ACCESSION NUMBER: 0001209191-16-151019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161115
FILED AS OF DATE: 20161117
DATE AS OF CHANGE: 20161117
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC
CENTRAL INDEX KEY: 0001088856
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770487658
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650.688.8803
MAIL ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tammenoms Bakker Juliet
CENTRAL INDEX KEY: 0001431159
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50679
FILM NUMBER: 162006241
MAIL ADDRESS:
STREET 1: LONGITUDE CAPITAL MANAGEMENT CO., LLC
STREET 2: 800 EL CAMINO REAL, SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Longitude Capital Partners, LLC
CENTRAL INDEX KEY: 0001430720
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50679
FILM NUMBER: 162006242
BUSINESS ADDRESS:
STREET 1: 800 EL CAMINO REAL
STREET 2: SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-854-5700
MAIL ADDRESS:
STREET 1: 800 EL CAMINO REAL
STREET 2: SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Longitude Capital Associates, L.P.
CENTRAL INDEX KEY: 0001430719
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50679
FILM NUMBER: 162006243
BUSINESS ADDRESS:
STREET 1: 800 EL CAMINO REAL
STREET 2: SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-854-5700
MAIL ADDRESS:
STREET 1: 800 EL CAMINO REAL
STREET 2: SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Longitude Venture Partners L.P.
CENTRAL INDEX KEY: 0001419701
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50679
FILM NUMBER: 162006244
BUSINESS ADDRESS:
STREET 1: 800 EL CAMINO REAL
STREET 2: SUITE 220
CITY: Menlo Park
STATE: ca
ZIP: 94025
BUSINESS PHONE: 650-854-5700
MAIL ADDRESS:
STREET 1: 800 EL CAMINO REAL
STREET 2: SUITE 220
CITY: Menlo Park
STATE: ca
ZIP: 94025
FORMER NAME:
FORMER CONFORMED NAME: Longitude Venture Partners LP
DATE OF NAME CHANGE: 20071128
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-11-15
0
0001088856
CORCEPT THERAPEUTICS INC
CORT
0001419701
Longitude Venture Partners L.P.
C/O LONGITUDE CAPITAL PARTNERS, LLC
800 EL CAMINO REAL, SUITE 220
MENLO PARK
CA
94025
0
0
1
0
0001430719
Longitude Capital Associates, L.P.
800 EL CAMINO REAL SUITE 220
MENLO PARK
CA
94024
0
0
1
0
0001430720
Longitude Capital Partners, LLC
800 EL CAMINO REAL SUITE 220
MENLO PARK
CA
94024
0
0
1
0
0001431159
Tammenoms Bakker Juliet
800 EL CAMINO REAL SUITE 220
MENLO PARK
CA
94024
0
0
1
0
Common Stock
2016-11-15
4
S
0
154359
9.5534
D
14362573
D
Common Stock
2016-11-15
4
S
0
3094
9.5534
D
191864
I
By LCA
Common Stock
2016-11-16
4
S
0
17052
9.5087
D
14345521
D
Common Stock
2016-11-16
4
S
0
342
9.5087
D
191522
I
By LCA
Reflects sales of common stock executed in multiple transactions at prices ranging from $9.5000 to $9.7200. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.
Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP"). This report is filed jointly by LVP, Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of LVP, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.
Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. ("LCA"). This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.
Reflects sales of common stock executed in multiple transactions at prices ranging from $9.5000 to $9.5450. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.
/s/ Juliet Tammenoms Bakker, as managing member of Longitude Capital Partners, LLC, as general partner of Longitude Venture Partners, L.P.
2016-11-17
/s/ Juliet Tammenoms Bakker, as managing member of Longitude Capital Partners, LLC, as general partner of Longitude Capital Associates, L.P.
2016-11-17
/s/ Juliet Tammenoms Bakker, as managing member of Longitude Capital Partners, LLC
2016-11-17
/s/ Juliet Tammenoms Bakker
2016-11-17